GCPIII/NAALADase II

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CART-138 (Chinese PLA General Hospital)Phase 2 ClinicalPla General HospitalLiver Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Breast Neoplasms; Brain Neoplasms; Colorectal Neoplasms
Details
ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center)Phase 1 ClinicalUnc Lineberger Comprehensive Cancer CenterMultiple Myeloma; Immune System Diseases
Details
  • Product Inquiry
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland